Status:

COMPLETED

Reliability and Validity of the IASP Clinical Criteria for Identifying Patients with Nociplastic Pain

Lead Sponsor:

University of Thessaly

Collaborating Sponsors:

KAT General Hospital

Conditions:

Chronic Pain

Central Sensitisation

Eligibility:

All Genders

18-65 years

Brief Summary

This protocol will report on the validation of IASP clinical criteria for indentifying nociplastic pain. The study will include 2 phases. In the first phase, the vignette method will be used while the...

Detailed Description

For the purposes of the study, in the first phase, clinical vignettes will be created, ie short hypothetical scenarios of patients with chronic musculoskeletal pain. The vignettes will feature patient...

Eligibility Criteria

Inclusion

  • Adult patients 18-65 years
  • with pain \> 3months, intensity of at least 3 on a 0-10 numerical pain rating scale on most days
  • or patients with fibromyalgia (according to the "criteria for classification of fibromyalgia" by the American college of rheumatology (Wolfe et al 1990)).

Exclusion

  • Patients who follow a physical therapy program
  • Recent surgery or trauma
  • Pregnant women,
  • Patients with neurological disorders or systemic diseases

Key Trial Info

Start Date :

February 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 2 2024

Estimated Enrollment :

94 Patients enrolled

Trial Details

Trial ID

NCT04730791

Start Date

February 1 2021

End Date

December 2 2024

Last Update

December 9 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Clinical Exercise Physiology and Rehabilitation Laboratory

Lamia, Central Greece, Greece, 35100

2

KAT Attica General Hospital

Athens, Greece